Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
mediaposted on 2021-02-25, 16:35 authored by Dimitrios A. Pappas, Taylor Blachley, Jennie H. Best, Steve Zlotnick, William G. Reiss, Kelechi Emeanuru, Joel M. Kremer
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.